Effect of Subanesthetic Dose of Esketamine on Perioperative Neurocognitive Disorders in Elderly Undergoing Gastrointestinal Surgery: A Randomized Controlled Trial
Chao Han,Haiyan Ji,Yaxin Guo,Yuanhui Fei,Chunhui Wang,Yanbo Yuan,Zhihui Ruan,Tieliang Ma
DOI: https://doi.org/10.2147/DDDT.S401161
2023-03-22
Abstract:Chao Han, 1, 2 Haiyan Ji, 1 Yaxin Guo, 1 Yuanhui Fei, 1 Chunhui Wang, 1 Yanbo Yuan, 1 Zhihui Ruan, 1 Tieliang Ma 1, 2 1 Department of Anesthesiology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu, 214200, People's Republic of China; 2 Yixing Clinical College, Medical College of Yangzhou University, Yixing, Jiangsu, 214200, People's Republic of China Correspondence: Chao Han, Department of Anesthesiology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu, 214200, People's Republic of China, Tel +86 13961568178, Fax +86 051087921010, Email Background: Perioperative neurocognitive disorders (PND), including delayed neurocognitive recovery (dNCR) and postoperative cognitive dysfunction (POCD), are common postoperative complications in elderly patients and adversely affect their prognosis. The study was designed to explore the effects of esketamine on postoperative cognitive function in elderly patients who underwent gastrointestinal surgery under general anesthesia and its potential mechanism. Methods: Eighty-four patients aged 65 and above undergoing gastrointestinal surgery were randomly divided into 2 groups: the esketamine group (group S) and the control group (group C). Group S received intravenous sub-anesthetic doses of esketamine (0.15 mg/kg) 5 minutes before the initiation of surgery, while group C received the same volume of saline. A battery of neuropsychological tests was used to assess cognitive function before surgery, 7 days, and 3 months after surgery. The primary outcome was the incidence of dNCR at 7 days postoperatively and POCD at 3 months postoperatively in both groups. The secondary outcome measures included changes in the levels of serum interleukin-6 (IL-6) and calcium-binding protein β (S100β) before and 1 day after surgery. Results: The incidence of dNCR in group S was lower than that of group C (18.15% vs 38.24% P=0.033). Contrarily, there was no difference in both groups regarding POCD 3 months postoperatively (6.06% vs 14.37% P=0.247). Plasma IL-6 and S100β levels were significantly elevated in both groups on postoperative day 1 (p< 0.05), but esketamine pretreatment reduced these levels to some extent compared with group C (p< 0.05). Conclusion: Sub-anesthetic doses of esketamine might reduce the incidence of dNCR and improve early postoperative cognitive function in elderly patients undergoing gastrointestinal surgery, which might be related to the anti-neuroinflammation effects of esketamine. Keywords: esketamine, perioperative neurocognitive disorders, gastrointestinal surgery, elderly, neuroinflammatory Cognitive impairment following anesthesia and surgery is a common complication in elderly individuals, mainly manifested falls in memory, attention, information processing, and cognitive flexibility. 1 In 2018, new recommendations for the nomenclature of cognitive change associated with anesthesia and surgery recommended perioperative neurocognitive disorders (PND) as an overarching term for cognitive decline identified in the perioperative period, including acute postoperative delirium (POD), delayed neurocognitive recovery (within the 30 days recovery period, dNCR), and postoperative neurocognitive dysfunction (from expected recovery 30 days to 12 months, POCD). 2,3 Previous studies have shown that patients aged 65 and above who underwent non-cardiac surgery had a 26% prevalence of POCD 1 week after surgery which decreased to 10% 3 months postoperatively. 4 PND is associated with delayed recovery, prolonged hospital stays, additional healthcare expenditures, and even increased probability for 1-year postoperative mortality. 5 However, up to date, limited treatment options for PND are available and the exact mechanism remains unclear. Several studies have suggested that neuro-inflammation induced by surgery and anesthesia is a major contributor to the development of POCD. 6,7 It is well known that aseptic surgical trauma causes inflammation at the surgical site, which is amplified via peripheral pro-inflammatory cytokines, and this leads to disruption of the blood–brain barrier (BBB), allowing pro-inflammatory cytokines to enter the central nervous system (CNS) and activate microglia. Once activated, microglia continue to up-regulate the expression of pro-inflammatory cytokines, thus amplifying neuro-inflammation could lead to neuronal apoptosis and contribute to the development of POCD. 8,9 Ketamine, formerly referred to as a "dissociative anesthetic", has reemerged as a useful anesthetic/analgesic agent. The unique properties of ketamine and its large versatility -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal